China's Regulatory Crackdown / Life Science Stock Picks

<p>China is still an engine of global growth, says Patrick Todd of Harding Loevner's International Equity Fund (HLMIX). Regulatory crackdown raises questions about the future of many firms. He is looking at the five year plans. He thinks local research and development companies will benefit from increased spending. He sees opportunities in the stocks of life science companies including Illumina (ILMN), Mettler Toledo (MTD), and Abcam (ABCM). </p><p><br></p>